AU2002359694A8 - Compounds and methods - Google Patents

Compounds and methods

Info

Publication number
AU2002359694A8
AU2002359694A8 AU2002359694A AU2002359694A AU2002359694A8 AU 2002359694 A8 AU2002359694 A8 AU 2002359694A8 AU 2002359694 A AU2002359694 A AU 2002359694A AU 2002359694 A AU2002359694 A AU 2002359694A AU 2002359694 A8 AU2002359694 A8 AU 2002359694A8
Authority
AU
Australia
Prior art keywords
compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002359694A
Other versions
AU2002359694A1 (en
Inventor
M Dominic Ryan
Lara S Kallander
Scott K Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2002359694A1 publication Critical patent/AU2002359694A1/en
Publication of AU2002359694A8 publication Critical patent/AU2002359694A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002359694A 2001-12-14 2002-12-13 Compounds and methods Abandoned AU2002359694A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34064601P 2001-12-14 2001-12-14
US60/340,646 2001-12-14
PCT/US2002/039845 WO2003051906A2 (en) 2001-12-14 2002-12-13 Compounds and methods

Publications (2)

Publication Number Publication Date
AU2002359694A1 AU2002359694A1 (en) 2003-06-30
AU2002359694A8 true AU2002359694A8 (en) 2003-06-30

Family

ID=23334335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002359694A Abandoned AU2002359694A1 (en) 2001-12-14 2002-12-13 Compounds and methods

Country Status (2)

Country Link
AU (1) AU2002359694A1 (en)
WO (1) WO2003051906A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001024796A1 (en) 1999-10-01 2001-04-12 Smithkline Beecham Corporation 1,2,4-triazole derivatives, composition, process of making and methods of use
AU2014216178B2 (en) 2013-02-15 2018-06-28 KALA BIO, Inc. Therapeutic compounds and uses thereof
US9688688B2 (en) 2013-02-20 2017-06-27 Kala Pharmaceuticals, Inc. Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
BR112015020139A2 (en) 2013-02-20 2017-07-18 Kala Pharmaceuticals Inc therapeutic compounds and their uses
KR20160099084A (en) 2013-11-01 2016-08-19 칼라 파마슈티컬스, 인크. Crystalline forms of therapeutic compounds and uses thereof
US9890173B2 (en) 2013-11-01 2018-02-13 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
WO2015089800A1 (en) 2013-12-19 2015-06-25 Eli Lilly And Company Fluorophenyl pyrazol compounds
WO2016113205A1 (en) 2015-01-13 2016-07-21 Bayer Pharma Aktiengesellschaft Substituted pentafluoroethyl pyrimidinones and use thereof
WO2016201662A1 (en) * 2015-06-18 2016-12-22 Eli Lilly And Company Fluoropyridyl pyrazol compounds
EP3509422A4 (en) 2016-09-08 2020-05-20 Kala Pharmaceuticals, Inc. Crystalline forms of therapeutic compounds and uses thereof
CN109688818A (en) 2016-09-08 2019-04-26 卡拉制药公司 Crystal form of therapeutic compounds and application thereof
AU2017324716B2 (en) 2016-09-08 2020-08-13 KALA BIO, Inc. Crystalline forms of therapeutic compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19636509A1 (en) * 1996-09-09 1998-03-12 Basf Ag New pyrazolyl-quinoline compounds

Also Published As

Publication number Publication date
AU2002359694A1 (en) 2003-06-30
WO2003051906A2 (en) 2003-06-26
WO2003051906A3 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
EP1423120A4 (en) 2h-phthalazin-1-ones and methods for use thereof
GB0128287D0 (en) Novel method and compounds
EP1313477A4 (en) Compounds and methods
EP1274424A4 (en) Compounds and methods
EP1434772A4 (en) Compounds and methods
GB0108968D0 (en) Methods
GB0120042D0 (en) Methods
AU2002359694A8 (en) Compounds and methods
GB0126251D0 (en) Methods
GB0126889D0 (en) Compounds and their uses
GB0125708D0 (en) Novel compounds and processes
GB0111146D0 (en) Methods
GB0116249D0 (en) Methods
EP1379240A4 (en) Compounds and methods
EP1343796A4 (en) Compounds and methods
GB0118549D0 (en) Methods
GB0118611D0 (en) Methods
GB0119009D0 (en) Compound and process
GB0116076D0 (en) Methods
GB0112053D0 (en) Bacsac
GB0119796D0 (en) Novel method and compounds
GB0116178D0 (en) Novel method and compounds
GB0111206D0 (en) Novel method and compounds
GB0108975D0 (en) Novel method and compounds
GB0108974D0 (en) Novel method and compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase